The cytokine-mediated suppression of ADAMTS13 activity results in VWF imbalances, which lead to microvascular thrombosis and unfavorable clinical outcomes, particularly in patients with disseminated intravascular coagulation [31,32]. This evidence concerns the gene ADAMTS13 and deep vein thrombosis.